45
Development of biosimilar medicines - patent issues.ppt
Development of biosimilar medicines - patent issues
32
Population Pharmacokinetic and Pharmacodynamic Model-Based Comparability Assessment of a Recombinant Human Epoetin Alfa and the Biosimilar HX575.pdf
Population Pharmacokinetic and Pharmacodynamic Model-Based Comparability Assessment of a Recombinant Human Epoetin Alfa and the Biosimilar HX575
30
Parallel experimental design and multivariate analysis provides efficient screening of cell culture media supplements to improve biosimilar product quality.pdf
Parallel experimental design and multivariate analysis provides efficient screening of cell culture media supplements to improve biosimilar product qualityParallel experimental design and multivariate analysis provides efficient screening of cell culture media supplements to improve biosimilar product qualityParallel experimental design and multivariate analysis provides efficient screening of cell culture media supplements to improve biosimilar product quality
37
clinical similarity of the biosimilar abp 501 compared with adalimumab after single transition long-term results from a randomised, double-blind, 5.pdf
AcceptedArticleAccepted ArticleThis article has been accepted undergonefull peer review beenthrough
34
efficacy and safety of biosimilar (sar342434 insulin lispro) in adults with type 1 diabetes also using insulin glargine-sorella 1 study.[2017][diab.pdf
efficacy and safety of biosimilar (sar342434 insulin lispro) in adults with type 1 diabetes also using insulin glargine-sorella 1 study.[2017][diab
39
nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (basaglar(r)abasaglar(r)) approved in the european un.pdf
nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (basaglar(r)abasaglar(r)) approved in the european un
97
Development of Biopharmaceuticals and Biosimilar Drug Delivery(PPT-97).ppt
文档标题《Development of Biopharmaceuticals and Biosimilar Drug Delivery》,总页数为97页,主要介绍了与<Development of Biopharmaceuticals and Biosimilar Drug Delivery>相关的资料,希望对大家有用,欢迎大家浏览!
11
a randomized, double-blind, efficacy and safety study of pf-05280586 (a rituximab biosimilar) compared with rituximab reference product (mabthera((.pdf
a randomized, double-blind, efficacy and safety study of pf-05280586 (a rituximab biosimilar) compared with rituximab reference product (mabthera((
13
population pharmacokinetic modeling of pf-06439535 (a bevacizumab biosimilar) and reference bevacizumab (avastin((r))) in patients with advanced no.pdf
population pharmacokinetic modeling of pf-06439535 (a bevacizumab biosimilar) and reference bevacizumab (avastin((r))) in patients with advanced no

向豆丁求助:有没有biosimilar?

如要投诉违规内容,请联系我们按需举报;如要提出意见建议,请到社区论坛发帖反馈。